Navigation Links
Standard & Poor's Announces Changes to U.S. Indices
Date:11/11/2008

NEW YORK, Nov. 11 /PRNewswire/ --Standard & Poor's will make the following changes to the S&P 500 and S&P MidCap 400 indices:

-- General Growth Properties Inc. (NYSE Arca: GGP) will be removed from the

S&P 500 after the close of trading on Wednesday, November 12. As of

today's close of trading General Growth Properties had a market

value of approximately $128 million, ranking 500th in the index.

-- S&P MidCap 400 constituent Cephalon Inc. (Nasdaq: CEPH) will be

added to the S&P 500, and Mariner Energy Inc. (NYSE: ME) will

replace Cephalon Inc. in the S&P MidCap 400, after the close of

trading on Friday, November 14. Cephalon is taking the place of

General Growth Properties in the S&P 500.

Standard & Poor's will monitor these transactions, and post any relevant updates on its website: http://www.standardandpoors.com.

Cephalon is a biopharmaceutical developer specializing in products related to the central nervous system, pain, oncology and addiction. Headquartered in Frazer, PA, the company will be added to the S&P 500 GICS (Global Industry Classification Standard) Biotechnology Sub-Industry index.

Mariner Energy is an oil and gas exploration, development and production company operating principally in the Gulf of Mexico and the Permian Basin in West Texas. Headquartered in Houston, TX, the company will be added to the S&P MidCap 400 GICS Oil & Gas Exploration & Production Sub-Industry index.

Following is a summary of the changes:

S&P 500 INDEX - November 12, 2008

COMPANY GICS ECONOMIC SECTOR GICS SUB-INDUSTRY

DELETED General Growth Financials Retail REITs

Properties

S&P 500 INDEX - November 14, 2008

COMPANY GICS ECONOMIC SECTOR GICS SUB-INDUSTRY

ADDED Cephalon Health Care Biotechnology

S&P MIDCAP 400 INDEX - November 14, 2008

COMPANY GICS ECONOMIC SECTOR GICS SUB-INDUSTRY

ADDED Mariner Energy Energy Oil & Gas

Exploration &

Production

DELETED Cephalon Health Care Biotechnology

Additions to and deletions from an S&P equity index do not in any way reflect an opinion on the investment merits of the companies concerned.

About Standard & Poor's Index Services

Standard & Poor's Index Services, the world's leading index provider, maintains a wide variety of investable and benchmark indices to meet an array of investor needs. Its family of indices includes the S&P 500, an index with $1.5 trillion invested and $4.85 trillion benchmarked, and the S&P Global 1200, a composite index comprised of seven regional and country headline indices. For more information, please visit http://www.standardandpoors.com/indices.

About Standard & Poor's

Standard & Poor's, a division of The McGraw-Hill Companies (NYSE: MHP), is the world's foremost provider of financial market intelligence, including independent credit ratings, indices, risk evaluation, investment research and data. With approximately 8,500 employees, including wholly owned affiliates, located in 23 countries and markets, Standard & Poor's is an essential part of the world's financial infrastructure and has played a leading role for more than 140 years in providing investors with the independent benchmarks they need to feel more confident about their investment and financial decisions. For more information, visit http://www.standardandpoors.com.


'/>"/>
SOURCE Standard & Poor's
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Osteotechs Next Generation Grafting Material, MagniFuse(TM) Bone Graft, a Breakthrough in Bone Regeneration; MagniFuse(TM) Bone Graft seeks to redefine the standard of care in the U.S. bone graft substitute market estimated to be in excess of $1.2 billio
2. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
3. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
4. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
5. Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices
6. Mymetics Corporation Information to be Available Through Standard & Poors Market Access Program
7. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
8. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
9. Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science
10. Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy
11. WuXi AppTec VP and GM Invited to Join the AAMI Standards Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... 2016 , ... In a new case report published today in STEM CELLS ... developed lymphedema after being treated for breast cancer benefitted from an injection of stem ... with this debilitating, frequent side effect of cancer treatment. , Lymphedema refers ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
Breaking Biology Technology:
(Date:6/2/2016)... 2, 2016 Perimeter Surveillance & ... Systems, Physical Infrastructure, Support & Other Service  ... offers comprehensive analysis of the global Border ... generate revenues of $17.98 billion in 2016. ... a leader in software and hardware technologies for advanced ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):